Inspired by the multi-functionality of vitamin D-binding protein and the multiple transientbinding behavior of some intrinsically disordered proteins (IDPs), we have designed, prepared and characterized a polymeric platform for combined delivery of dermal protective and anticancer bioactive cargos based on artificial single-chain nano-objects mimicking IDPs. For the first time ever, simultaneous delivery of folic acid, or vitamin B 9 , and hinokitiol, a -2 -relevant natural bioactive compound that exhibits anticancer activity against human malignant melanoma cells, from these multi-directionally self-assembled unimolecular nanocarriers is illustrated.
Introduction
The vitamin D-binding protein (DBP) or GC-globulin, identified about a half a century ago, [1] is a multi-functional protein found in human serum that binds and transports various forms of vitamin D, as well as other biomolecules like actin or fatty acids. DBP´s main function is to retain vitamin D for the organism and make it available to various tissues and cell types for usage. [2] Various forms of vitamin D, such as D3 (cholecalciferol), D2 (ergocalciferol), 25D
(25-hydroxy-vitamin D) and 1,25D (1,25-dihydroxy-vitamin D), the active form of vitamin D, are bound to DBP via a surface vitamin D-binding cleft in one of the three domains of the protein. [3] The affinity constants for 25D-, 1,25D-, actin-and fatty acid-binding to BDP are 7×10 8 M -1 , 4×10 7 M -1 , 1×10 9 M -1 and 6-7×10 5 M -1 , respectively. [4] In contrast to globular proteins adhering to the classical structure-function paradigm, intrinsically disordered proteins (IDPs) lack a well-defined unique structure, adopting in solution a complete ensemble of rapidly interconverting conformations. [5] Interestingly, in spite of its disordered structure, IDPs can bind several ligands, such as ions, small organic molecules, other proteins and nucleic acids (RNA, DNA). The interplay between structure and function in IDPs has not been recognized until very recently and it is not completely understood yet. [6] Although some IDPs are simple coils that bond together other proteins, most of them have transient-binding or permanent-binding recognition sites. Moreover, a large number of IDPs exhibit what is referred to as binding promiscuity. [7] Recently, we have reported that the structure of multi-directionally self-assembled singlechain polymer particles (SCNPs) under good solvent conditions closely resemble that of IDPs -3 -in solution. [8] Kratky plots from small angle neutron scattering (SANS) measurements showed a structure factor in close analogy to that of disordered multi-domain proteins (e.g., p67 phox ) so, from a structural point of view, they could be considered, to a good approximation, as artificial mimics of IDPs and denoted as IDPMs. It is worth mentioning that the Kratky plot has the capacity to enhance particular features of scattering profiles, thus allowing easier identification of degrees of compactness. [5] Hence, according to SANS results SCNPs in good solvents show multiple local-scale domains separated by flexible linkers, whereas SCNPs in the dry state adopt a globular morphology, as observed by TEM. Moreover, in this previous study the ability of the SCNPs to deliver vitamin B 9 in water at neutral pH was assessed. The delivery curve of vitamin B 9 was fitted to a power law model from which the value of the release exponent was found to be ca. 0.5, suggesting that the process proceeds through a
Fickian diffusion mechanism and completes in less than 5 hours. [8] We hypothesized that in analogy to some disordered proteins, IDPMs could also have some degree of binding promiscuity towards some relevant bioactive compounds that could be then delivered to water in a pH-dependent manner. In particular, we investigate herein the potential use of SCNPs as artificial IDPM nanocarriers for simultaneous delivery of both dermal protective and anticancer cargos (see Fig. 1A ). As a model system of dermal protective compounds, we selected folic acid (also known as folate or vitamin B 9 ), 1.
According to several in vitro and in vivo studies, dermal delivery of 1 using topical formulations offers a treatment option for photo-aged skin. [9, 10] As a natural anticancer drug, we selected hinokitiol (β-thujaplicin), 2, as a tropolone-related compound found in heartwood of cupressaceous plants that exhibits anticancer activity against human malignant melanoma cells [11] as well as other cancer cell lines, including the human leukemic cell K562 and the human stomach cancer cell KATO-III. [12, 13] The selective anticancer mechanism of 2 in melanoma cancer cells versus normal human melanocytes has been recently reported to involve strong G1 cell cycle arrest due to p27 protein accumulation, down-regulation of Skp2 -4 -proteins, and inhibition of Cdk2 kinase activity. [14] As a proof of concept we will demonstrate, for the first time ever, the simultaneous delivery of 1 and 2 to water solutions at different pH values from SCNPs as artificial IDPM nanocarriers.
Results and Discussion

Design of intrinsically disordered protein mimetics (IDPMs)
The design of intrinsically disordered protein mimetics, IDPMs, was guided by molecular dynamics (MD) simulations. In particular, coarse-grained MD simulations were performed to investigate the effect of different parameters, such as precursor chain length and functionality of reactive groups along the chain on the final structure and morphology of the resulting
IDPMs in solution. A detailed description of the MD simulations performed is provided in the
Supplementary Information (SI). In brief, a precursor chain of N beads of radius  having a fraction of monomers x = 0.2 of functionality f, able to form permanent intrachain cross-links, was first equilibrated as a self-avoiding random walk (i.e. good solvent conditions). Then, MD simulations were carried out allowing the progressive formation of irreversible links between reactive monomers in the chain if the distance between monomers is lower than a certain capture radius (1.3). Once the intrachain cross-linking process was completed, the average radius of gyration (R g ) of the resulting nano-objects was determined. [15] [16] [17] [18] [19] [20] [21] Based on the MD simulation results, IDPM size was found to depend more strongly on precursor length than on the functionality of the reactive groups. In order to define the structure of the nanoparticles taking into account multi-body correlations among the monomers, we use the Euler characteristic as a topological fingerprint [22, 23] . In 
Preparation and characterization of IDPMs
Guided by the MD simulation results, we target a precursor molecular weight of 3 × Michael acceptors. [8] This method produces robust, covalent bonded single-chain nanoobjects. [24, 25] The effect of precursor concentration during the synthesis of IDPMs on nanoobject size and size distribution is summarized in Table 1 , as determined by combined SEC/SLS and complementary DLS measurements. By working at 3 mg/ml, an increase in the value of the actual molecular weight was observed even when a moderate reduction in the values of R h and R g was clearly observed. Upon decreasing the precursor concentration to 1 mg/ml, the absolute molecular weight values at the SEC peak maximum of the precursor and the IDPMs were found to be very similar, and a larger reduction in the values of R h and R g was found. No further reduction was observed by working at precursor concentrations < 1 mg/ml. In this sense, it is worth mentioning that potential intermolecular cross-linking events are increasingly avoided by passing from a semi-concentrated to a highly diluted solution. [26, 27] A vertical shift (downward) in the curve of R g versus t R was observed upon nano-object formation (see Fig. 3A ) which can be attributed to a change in the R g /R h ratio on passing from linear coils to IDPMs. For a flexible polymer chain under good solvent conditions R g /R h ≈ 1.56, whereas for globular particles R g /R h ≈ 0.77. [28] IDPMs synthesized at 3 mg/ml show a ratio of R g /R h = 1.25, whereas IDPMs synthesized at 1 mg/ml display R g /R h = 1.05, the latter being a value intermediate between those expected for a coil and a globule.
The collapse degree (R g (IDPM) / R g (Precursor)
) for nanoparticles (f = 3) synthesized at 1 mg/ml was 0.55, in good agreement with the value estimated from MD simulations. According to data summarized in Table 1 , IDPM-1 shows a structure more collapsed than IDPM-3.
The typical morphology of the IDPMs under good solvent conditions was deduced from SAXS measurements, showing a Kratky plot resembling that observed in natural intrinsically disordered proteins and very different from that of the linear precursor (see Fig. -7 -3B). [5] As expected, SAXS results were in good agreement with previous SANS and MD simulation data. [8] Conversely, the morphology of individual IDPMs in the dry state was undoubtedly globular, as observed by TEM, showing collapsed nanoparticles with a spherical shape (Fig. 3C). 
Combined delivery of dermal bioactive cargos from IDPMs
To test our hypothesis of IDPM multi-binding ability, the nanocarriers were loaded with both folic acid (1) and hinokitiol (2) and the controlled delivery of these protective and anticancer dermal bioactive cargos, respectively, in water at two relevant pH values (pH = 6 and pH = 8)
was monitorized by UV spectroscopy. For quantifying the delivery process, the intensities of the UV absorption maxima of 1 and 2 at 283 nm and 240 nm, respectively, as well as appropriate calibration curves, were employed (see Figs. S3, S4) . Figure 3D illustrates the experimental data corresponding to the simultaneous delivery of 1 and 2 at pH = 6 and pH = 8 from IDPMs loaded with 51 % of dermal bioactive compounds (ratio 2 : 1 = 0.53). According to these data, on average, there are 410 molecules of 2 and 170 molecules of 1 per IDPM carrier. The delivery process for both compounds was faster at pH = 8 than at pH = 6, especially at short delivery time, whereas total delivery was found to take place in about 4 hours at both pH values. All our attempts to characterize the presumably weak 1/IDPM and 2/IDPM interactions under the high diluted experimental conditions by 1 H NMR, UV-vis and FTIR spectroscopies failed. Nevertheless, the simultaneous delivery of 1 and 2 to water solutions at relevant pH values from SCNPs as artificial IDPM nanocarriers pave the way to the long-term development of multifunctional topical formulations containing IDPMs.
Conclusion
Guided by MD simulations results we have developed and characterized single-chain 
